3.7(top 10%)
impact factor
1.3K(top 20%)
papers
23.6K(top 10%)
citations
61(top 10%)
h-index
3.9(top 10%)
impact factor
1.7K
all documents
25.7K
doc citations
89(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Polypharmacology: drug discovery for the futureExpert Review of Clinical Pharmacology2013362
2Corticosteroids in brain cancer patients: benefits and pitfallsExpert Review of Clinical Pharmacology2011263
3Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promisingExpert Review of Clinical Pharmacology2011262
4A perspective on the epidemiology of acetaminophen exposure and toxicity in the United StatesExpert Review of Clinical Pharmacology2014196
5Therapeutic potential of KCa3.1 blockers: recent advances and promising trendsExpert Review of Clinical Pharmacology2010172
6From pharmaceuticals to nutraceuticals: bridging disease prevention and managementExpert Review of Clinical Pharmacology2019170
7The pharmacokinetics of Toll-like receptor agonists and the impact on the immune systemExpert Review of Clinical Pharmacology2011163
8TargetingN-methyl-D-aspartate receptors for treatment of neuropathic painExpert Review of Clinical Pharmacology2011162
9Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidenceExpert Review of Clinical Pharmacology2021144
10Homocysteine and the pathogenesis of atherosclerosisExpert Review of Clinical Pharmacology2015143
11Nutraceuticals - shedding light on the grey area between pharmaceuticals and foodExpert Review of Clinical Pharmacology2018140
12Modeling and predicting drug pharmacokinetics in patients with renal impairmentExpert Review of Clinical Pharmacology2011138
13Dupilumab for treatment of atopic dermatitisExpert Review of Clinical Pharmacology2018135
14Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviewsExpert Review of Clinical Pharmacology2018134
15The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Review of Clinical Pharmacology2013133
16Blinding and expectancy confounds in psychedelic randomized controlled trialsExpert Review of Clinical Pharmacology2021133
17Brain injury with diabetes mellitus: evidence, mechanisms and treatment implicationsExpert Review of Clinical Pharmacology2017128
18STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progressExpert Review of Clinical Pharmacology2020121
19Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysisExpert Review of Clinical Pharmacology2012116
20Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyExpert Review of Clinical Pharmacology2012114
21Mesalamine in the treatment and maintenance of remission of ulcerative colitisExpert Review of Clinical Pharmacology2012112
22Proton pump inhibitors: use and misuse in the clinical settingExpert Review of Clinical Pharmacology2018112
23Understanding and preventing drug–drug and drug–gene interactionsExpert Review of Clinical Pharmacology2014110
24Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Expert Review of Clinical Pharmacology2015108
25Pharmacovigilance in resource-limited countriesExpert Review of Clinical Pharmacology2015107
26Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptivesExpert Review of Clinical Pharmacology2010102
27Perils and pitfalls of long-term effects of proton pump inhibitorsExpert Review of Clinical Pharmacology2013101
28Sex and gender influences on pharmacological response: an overviewExpert Review of Clinical Pharmacology201499
29Therapeutic drug monitoring of anti-infective agents in critically ill patientsExpert Review of Clinical Pharmacology201698
30NSAID induced gastrointestinal damage and designing GI-sparing NSAIDsExpert Review of Clinical Pharmacology201898
31Innovative clinical trial design for pediatric therapeuticsExpert Review of Clinical Pharmacology201196
32Cancer prevention and treatment using combination therapy with natural compoundsExpert Review of Clinical Pharmacology202092
33Statins stimulate atherosclerosis and heart failure: pharmacological mechanismsExpert Review of Clinical Pharmacology201591
34Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug responseExpert Review of Clinical Pharmacology201289
35LDL-C does not cause cardiovascular disease: a comprehensive review of the current literatureExpert Review of Clinical Pharmacology201888
36Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicityExpert Review of Clinical Pharmacology201084
37Adverse effects in women: implications for drug development and regulatory policiesExpert Review of Clinical Pharmacology201184
38Psychopharmacological advances in eating disordersExpert Review of Clinical Pharmacology201884
39Clinical and pharmacological profile of benznidazole for treatment of Chagas diseaseExpert Review of Clinical Pharmacology201884
40Acid peptic diseases: pharmacological approach to treatmentExpert Review of Clinical Pharmacology200983
41PD-1/PD-L1 pathway inhibitors in advanced prostate cancerExpert Review of Clinical Pharmacology201883
42Managing the adverse effects of nonsteroidal anti-inflammatory drugsExpert Review of Clinical Pharmacology201182
43Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®)Expert Review of Clinical Pharmacology201481
44The pharmacological management of metabolic syndromeExpert Review of Clinical Pharmacology201880
45Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugsExpert Review of Clinical Pharmacology202079
46Nanoparticles as potential clinical therapeutic agents in Alzheimer’s disease: focus on selenium nanoparticlesExpert Review of Clinical Pharmacology201777
47G-quadruplex interacting small molecules and drugs: from bench toward bedsideExpert Review of Clinical Pharmacology201476
48Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGFExpert Review of Clinical Pharmacology201475
49Gemtuzumab ozogamicin for the treatment of acute myeloid leukemiaExpert Review of Clinical Pharmacology201875
50Therapeutic potential of new hydrogen sulfide-releasing hybridsExpert Review of Clinical Pharmacology201173